(MedPage Today) — This week’s topics include fecal transplant capsules, stem cells for macular degeneration, exercise and depression in teens, and Ebola predictions.
Category: News
IRIDEX to host Speakers’ Forum program at the American Academy of Ophthalmology
IRIDEX Corporation (Nasdaq: IRIX) announced today its Speakers’ Forum program at the annual meeting of the American Academy of Ophthalmology to be held on October 18 – 21 at McCormick Place in Chicago.
Discovery of a new mechanism that can lead to blindness
An important scientific breakthrough by a team of IRCM researchers led by Michel Cayouette, PhD, is being published today by The Journal of Neuroscience.
Safe to Just Observe Mild Vitreomacular Adhesion?
A study looks at the outcomes of patients with vitreomacular adhesion who are managed with observation. Medscape Ophthalmology
Embryonic Stem Cells Improve Vision, Appear Safe at 22 Months
Phase 1/2 studies conducted in the United States are the first to report the long-term safety and possible biological activity of human embryonic stem cell transplants in human disease. Medscape Medical News
Significant Retinopathy Risk With Long-Term Hydroxychloroquine
Long-term use of hydroxychloroquine may carry a significant risk of toxic retinopathy, according to a retrospective case-control study. Reuters Health Information
How safe are human embryonic stem cell transplants?
Although the potential therapeutic uses of human embryonic stem cells have been known since 1981, until now, the long-term safety of these transplantations had not been assessed.
Embryonic Stem Cell Tx Bolsters Vision
(MedPage Today) — Findings spur optimism not celebration.
Healthcare Professionals: Get a Flu Vaccine or Risk Being a Fool
Healthcare providers have no excuse to avoid the flu vaccine; they have access to the world’s medical knowledge and should be able to rise above superstition and ignorance. Medscape Infectious Diseases
Eye Co receives patent for new class of eye disease drugs
Australian ocular technology company Eye Co Pty Ltd has achieved a key commercial milestone, with a patent granted protecting its new class of eye disease drugs throughout the high value European market.
American Academy of Ophthalmology (AAO) 2014 Annual Meeting
Read clinically focused news coverage of key developments from AAO 2014. Medscape Ophthalmology
Sneak Peek at AAO 2014
Dr Roger Steinert outlines the popular and not-to-miss sessions at this year’s American Academy of Ophthalmology meeting, and for those who can’t make it, the ‘virtual meeting’ is an option. Medscape Ophthalmology
Corneal Crosslinking in Keratitis: A 40-Eye Experience
A trial of corneal crosslinking in infectious keratitis raises more questions than it answers. Medscape Ophthalmology
USC to become a hub for exploring the human brain
In a rare distinction for one university, neuroimaging world leaders and USC Professors Arthur Toga and Paul Thompson will receive two major research center awards to advance their exploration of the human brain.
World watches as grandfather from Malawi has his sight restored live online
A blind man’s sight-restoring operation was broadcast live around the world at 1.30pm(BST) October 8, 2014 from a hospital in Malawi.
Over 123 million lost workdays per year caused by blindness or eye diseases according to new pan-European health economic study
The European Forum Against Blindness (EFAB) has revealed the results of an 11-country study (an extension to the data reported last year covering six countries) which reports on the economic impact…
Nano-drug for dry eyes brings relief with less trouble
Drug-infused nanoparticles applied only once a week appear to be as effective at relieving dry eyes as the standard three-drops-a-day medication, according to a new study.
Shire receives FDA guidance on regulatory path for investigational compound SHP 465
Shire plc today announced that it has received further guidance from the U.S. Food and Drug Administration on the regulatory path for SHP 465 (triple-bead mixed amphetamine salts MAS), an investigational oral stimulant medication being evaluated as a p…
Pitt researchers receive $1.25 million from Defense Department to make whole-eye transplantation a reality
University of Pittsburgh School of Medicine researchers have been awarded $1.25 million from the U.S.
Squints can be treated at any age – Examination of children important in their first year of life
Around four per cent of all newborn children have a squint. In about 50 per cent of cases, this can be corrected with appropriate glasses, however the other half require treatment for their squint…